跳至主要内容
临床试验/NCT00182247
NCT00182247终止3 期

D-Dimer and IPG for Recurrent Thrombosis (DIRECT) Study

Hamilton Health Sciences Corporation15 个研究点 分布在 2 个国家目标入组 600 人开始时间: 1998年12月最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
600
试验地点
15
主要终点
symptomatic DVT and PE in follow-up

研究概览

简要总结

To simplify and improve the diagnostic approach to patients with clinically suspected recurrent DVT by determining whether the results of the combination of IPG and d-dimer testing, using a whole blood agglutination assay, can be used in the management of such patients.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
0 Years 至 —(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • suspected deep vein thrombosis
  • history of previous DVT or PE

排除标准

  • comorbid condition limiting survival to less than 6 months
  • contraindication to contrast medium (allergy, renal dysfunction, creatinine > 150mcmol/L)
  • receiving long-term warfarin or heparin therapy
  • received full-dose heparin therapy for more than 48 hours
  • pregnancy
  • symptomatic for pulmonary embolism
  • absence of symptoms within 5 days of presentation
  • geographic inaccessibility which precludes follow-up

结局指标

主要结局

symptomatic DVT and PE in follow-up

次要结局

  • death
  • deep vein thrombosis diagnosed by venography in those
  • randomized to that intervention

研究者

申办方类型
Other

研究点 (15)

Loading locations...

相似试验